Diagnostic accuracy of a blood based biomarker panel for CRC detection
Marcia Cruz-Correa, MD, PhD, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico, comments on the potential of combining multiple biomarkers for early detection of colorectal cancer. Dr Cruz-Correa highlights that a pilot study using a combined panel of biomarkers, including Septin-9, showed a diagnostic accuracy of 75%, and emphasizes the importance of developing blood-based screening methods to increase adherence to screening tests, particularly in underserved communities, where early detection can significantly improve survival rates. This interview took place at the ASCO GI Cancers Symposium 2025 in San Francisco, CA. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
